Rectal neoplasms, Urogenital neoplasms Rectal neoplasms, Urogenital neoplasms
Conditions
Interventions
Sponsors
Miura Takuya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Histologically confirmed malignant tumor. 2) Total pelvic exenteration allow curative resection. 3) Eastern Cooperative Oncology Group performance status (PS) 0-1. 4) Age at enrollment must be 20 years or older. 5) Written informed concent.
Exclusion criteria
Exclusion criteria: 1) Distant metastasis (Not excluded after curative resection of distant metastases). 2) Difficulty in pneumoperitoneum (severe emphysema, severe heart failure, angle-closure glaucoma). 3) History of clinically serious cardiovascular disease (myocardial infarction, unstable angina, heart failure, stroke, pulmonary embolism, other thromboembolism, etc.) within 6 months prior to enrollment. 4) Patients with serious complications (interstitial pneumonia or pulmonary fibrosis, liver failure, active infection, etc.). 5) Other patients who are judged by the study physician to be inappropriate for the safe conduct of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30-day severe morbidity rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time Blood loss Intraoperative blood use Postoperative blood use Postoperative hospital stay Readmission rate within 30 days after surgery R0 rate Rate of conversion to open laparotomy Intraoperative complication rate | — |
Contacts
Public ContactTakuya Miura
Hirosaki University Hospital
Outcome results
None listed